TELL ME MORE
ABOUT THIS CLINICAL TRIAL for an INFANT MENINGOCOCCAL VACCINE
This is an Immunogenicity and Safety Study of a Quadrivalent Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants age 42 – 89 days old
Infant Meningococcal Vaccine
Study Location(s): Evansville Indiana
This study evaluates the safety and immunogenicity of a 4-dose series of the quadrivalent Meningococcal Polysaccharide (Serogroups A, C, Y, and W) in healthy infants and toddlers in comparison to MENVEO® when both are administered concomitantly with routine pediatric vaccines. Click here for more information on Meningococcal vaccines.
There is no cost to participate. Volunteers receive free vaccines and follow-up care. No insurance needed. Time and travel reimburrsement up to $400 may be available.
Watch a 2-minute video about Infant Meningococcal Vaccine
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Bowling Green Owensboro | Recruiting | 6 - 17 | $1150 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 65 | $500 | Request Info | |
| DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study with open-label extension in patients with moderate to severe eczema | Evansville | Coming Soon | 2+ (child through adult) | $560 - $1400 | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| IBS- CONSTIPATION An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Recruiting | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA 1. Fussy Baby Relief 2. Comparison Study | Evansville Owensboro | Enrolling | Newborns | 1. $150 + formula 2. $625 + formula | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| INFANT VACCINE Comparison Study between two pneumococcal vaccines | Bowling Green | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS NEPHRITIS A Safety, efficacy and tolerability study for patients with active Lupus Nephritis | Evansville | Enrolling | 18 - 75 | $4625 ($125 per visit) | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |